Sagga, Jemred R.
HRN: 01-03-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/12/2024
05/18/2024
IV
300mg
Q6
Acute Tonsilopharyngitis
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes